Animal and fungal cells (in contrast to prokaryotes) contain two distinct sets of related aminoacyl-tRNA synthetases (aaRSs) encoded by nuclear genes and functioning in cytosol and mitochondria. The structural differences between mitochondrial and cytoplasmic enzymes may reflect the functional adaptation to fulfil mitochondrial processes in addition to protein synthesis. Mitochondrial import of nuclear-encoded tRNAs has been described in yeast, plants and protozoans but it has not been observed in mammalian cells. Its established that mitochondrial lysyl-tRNA synthetase (MSK) plays a prominent role in the transport of tRNA into yeast mitochondria for complementation of mitochondrial tRNAs genes mutations. We tried to identify MSK homologues in mammalian cells with the help of monospecific antibodies against pre-MSK by ELISA and Western-blot analysis. We have identified cross-reactive proteins in mitochondrial and cytoplasmic fractions of mammalian cell lysates. These data, together with the results of crossaminoacylation on mitochondrial and cytoplasmic tRNAs, suggest the presence of common antigenic determinants in the mitochondrial and cytoplasmic lysyl-tRNA synthetases from higher animals.
Introduction. Aminoacyl-tRNA synthetases (aaRSs) (EC 6.1.1) -are a heterogeneous family of enzymes differing in size and subunit structure but catalyzing the same reaction of the selective attachment of amino acids to their cognate tRNAs. The animal and fungal cells (in contrast to prokaryotes) contain two different sets of related aaRSs encoded by nuclear genes, one set localized in the cytosol and functioning in the cytoplasmic protein synthesis while the second lo calized in mitochondria and functioning in the or ganella translation. In addition, plant cells posses the third set of aaRSs involved in the chloroplastic protein synthesis [1, 2] .
The molecular and catalytic properties of cyto plasmic enzymes have been extensively studied over the past 20 years. However, the information about mitochondrial aaRSs remained scarce so far. Studies of the organelle-specific synthetases are important for several reasons. The information about sequences of these enzymes contribute to better understanding of the evolution of this enzyme family. On the other hand, the structural differences between the mito chondrial and cytoplasmic enzymes reflect the func tional adaptations to fulfil mitochondrial processes in addition to the protein synthesis. For example, in fungi, certain mitochondrial aaRSs are involved in either the splicing of mitochondrial RNAs [1, 2] , or the import of tRNA from the cytoplasm [3 ] .
In the yeast Saccharomyces cerevisiae, the se lective import into mitochondria of one of the two cytoplasmic lysine isoacceptors, tRNA Lys CUU, requi res the integrity of the mitochondrial pre-protein import machinery as well as soluble cytosolic factors [4] . One of the essential import factors has been identified as the precursor of the mitochondrial lysyl-tRNA synthetase (pre-MSK). Furthermore, it has been shown that pre-MSK can selectively bind to the aminoacylated form of tRNA Lys CUU (and to im portable mutant tRNAs) and is, therefore, likely to act as a carrier for transport of the tRNA across the mitochondrial membrane [5] .
The mitochondrial import of nuclear-coded tRNAs appears to be a widely spread process among eukaryotes since it has been described not only in yeast but also in plants and protozoans [6, 7] . However, this process is likely not to occur in mammalian cells. Establishing artificial system of tRNA mitochondrial import in human cells could be of high biomedical interest because several human mitochondrial neurodegenerative and muscular dise ases (such as MERRF and MELAS syndromes and several cardiomyopathies) are associated with point mutations in mitochondrial tRNA genes [8 ] . Indeed, theoretically such defects should be cured by exp ressing functional tRNAs in the nucleus and impor ting them from the cytoplasm to mitochondria.
Because the mitochondrial lysyl-tRNA synthetase plays a prominent role in the transport of tRNA into yeast mitochondria, we tried to identify MSK homologues in mammalian cells with the help of mono specific polyclonal antibodies directed against the yeast pre-MSK by ELISA and Western-blot analysis. We have identified cross-reactive proteins in mito chondrial and cytoplasmic fractions of mammalian cells lysates possessing an electrophoretic mobility similar to that of yeast pre-MSK. These data, toge ther with the results of cross-aminoacylation studies on mitochondrial and cytoplasmic tRNAs, suggest the presence of common antigenic determinants in mito chondrial (mt) and cytoplasmic (ct) lysyl-tRNA syn thetases (LysRSs) from the mammals and allow us to suppose that mammalian mitochondrial and cyto plasmic lysyl-tRNA synthetases could be encoded by the same gene.
Materials and Methods. Protein G-Sepharose was from «Sigma-Aldrich» (USA); anti-rabbit IgG labelled by horse-radish peroxidase from «DAKO» (Den mark) ; unfractionated yeast cytoplasmic and Escheri chia coli tRNAs were from «Boehringer-Mannheim» (Germany); the immunoblotting detection ECL sys tem and [
14 C]-Lys from «Amersham» (USA); all other chemicals were from «Мегск» (Germany), «Sig-ma» (USA) and «Віо-Rad» (USA).
The high molecular weight complex of cyto plasmic aaRSs was purified from bovine and rabbit liver by the immunoprecipitation method on the affinity column with coupled monoclonal antibodies against rabbit cytoplasmic GluRS accordingly to the described method [9] .
Recombinant pre-MSK was obtained using the Pichya pastoris expression system («Invitrogen») and purified on DEAE-cellulose and Mono-Q Sepharose.
Isolation of mammalian mitochondria and prepa ration of a mitochondrial crude extract Mitochondria from rabbit liver were obtained as described in [10] with some modifications. Rabbit liver was briefly homogenized in buffer A: 25 mM Tris/HCl, pH 7.5, 2 mM EDTA, 1.5 mM CaCl 2 , 250 mM sucrose. Nuclei and cell debris were removed by two 5 min sequential centrifugation at low speed (1000 x g for 5 min) and mitochondria were collected by high-speed centri fugation (10000 xg for 10 min) and washed three times with 250 mM sucrose in ТЕ buffer (25 mM Tris/HCl, pH 7.5, 2 mM EDTA). The mitochondrial fraction in 250 mM sucrose and ТЕ was layered on a sucrose step-gradient consisting 50 %, 36 % and 20 % sucrose in buffer В (50 mM Tris/HCl, pH 7.5, 2 mM EDTA, 1 g/1 bovine serum albumin) and centrifuged at 25000 rpm (1 h, rotor Beckman SW27). Intact mitochondria collected from the 36 % sucrose layer were diluted in 4 volumes 0.5 M sorbitol and centrifuged at 22000 x g for 15 min.
To obtain a mitochondrial crude extract, pelleted mitochondria were suspended in buffer С (25 mM potassium phosphate, pH 7.5, 10 mM MgCl 2 , 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 % glycerol) and disrupted by sonication. Membranous debris were removed by centrifugation at 10000 x g, 50 min.
Protein concentration was estimated by the Brad ford method [11 ] .
Mitochondrial tRNA was purified from bovine liver mitochondria according to the method [12] .
Preparation of antibodies against pre-MSK. The partially purified protein (50 jug) was electrophorized in 12 % PAAG-SDS gel [13] and transferred onto a nitrocellulose filter. The colored band with apparent molecular weight consistent with that of pre-MSK was cut, dissolved in DMSO and used for immunization. Rabbit was immunized by 30-40 jug of pre-MSK extracted in DMSO with complete Freund's adjuvant (1:1, v/v). A booster of 30 jug of antigen in incomplete Freund's adjuvant was administered twice at 3 weeks intervals. The serum was collected, and immuno globulins were precipitated with ammonium sulfate buffer at 50 % of saturation, and then purified by three chromatographic steps on DEAE-cellulose, on Protein G-Sepharose (according to the Firm protocol) and on an affinity column with coupled antigen [14] to obtain high-affinity and specific anti-pre-MSK antibodies.
The specificity of antibodies fractions obtained at each purification step was controlled by the ELISA method and their purity was estimated by 12 % PAGE-SDS electrophoresis.
Western-blot analysis. Lysates (cytoplasmic and mitochondrial) of cells and organs were electrophorized in 12 % PAAG-SDS gel and transferred onto a nitrocellulose membrane. Washing and blocka ge of the membrane was done in TBS-T-M buffer (TBS buffer with 0Л % Tween-20 and 5 % dry milk) during at 1 h at 25 °С Incubation with antibodies in TBS-T-M was during 2 h at 25 °С After extensive washing with TBS-T-M, the filters were incubated with anti-rabbit IgG labelled by peroxidase in TBS-T-M during 2 h at 25 °С After extensive washing with TBS-T, the fluorogene ECL was added to the filters (according to the firm protocol) and after 10 min of incubation filters were autographied on an X-ray film («Kodak») for visualization of the signals.
Aminoacylation assay. Lysyl-tRNA synthetase aminoacylation test was performed in 0.1 ml of the mixture containing 100 mM Tris/HCl, pH 7.5, 30 mM KC1, 10 mM MgCl 2 , 2 mM ATP, 60 /Ш [ 3 H]-Lysine (60-80 Ci/mmol, «Amersham»), with saturating amounts of relevant unfractionated tRNA and limiting amounts of enzyme. A unit of activity corresponds to 1 nmol aminoacyl-tRNA formed at 37 °С The influence of antibodies on the aminoacylating activity of the mitochondrial and cytoplasmic lysyl-tRNA synthetases was detected according to the method [14] .
Results and Discussion. A problem of obtaining antibodies of high specificity and affinity is connected with the homogeneity of antigen, the scheme of immunization and the methods of antibodies purifica tion. The purification of majority of recombinant antigens is problematic without use of specific affine ligands. In our case the absence of such a ligand for the antigen (pre-MSK), low level of the recombinant protein secretion by producent and disability to purify the antigen to homogeneity put forward a problem of working out an effective method of immunization and following antibodies purification to produce antibodies of high titer and specificity.
Our scheme of immunization allowed us to obtain the antisera with titer more than 1:10000. The affinity of antibodies increased after each purification stage accompanied by simultaneous nonspecificity decre asing. Fig. 1 and Fig. 2 04, B) represent the immunoreactivity of the antibodies after different stages of purification. It is obvious that even after protein G-Sepharose chromatography (Fig. 1) the affinity of antibodies is not enough for the antigen detection in cell and tissue lysates. Only after their purification on the affine column with coupled antigen (pre-MSK) the affinity was considered satisfactory (Fig. 2) . The studies of antibodies immunoreactivity with cell and tissue lysates have shown that mentioned antibodies recognized the polypeptide band with electrophoretic mobility corresponding to that of LysRS subunit in the majority of the lysates investigated albumin (control of non-specificity); 2 -high molecular weight complex from bovine liver; 3 -mitochondrial lysate from bovine liver; 4 -cytoplasmic lysate (S100) from rabbit liver; 5 -lysate of yeast mitochon dria; 6 -cytoplasmic (S100) lysate of ye ast; 7 -pre-MSK (Fig. 3) . The occurence of several low molecular weight peptides in yeast lysate (Fig. 3, lane 6 ) is a result of high level of endogeneous proteolysis in yeast.
The study of he antibodies influence on the enzymatic activity of mammalian mtLysRS and ctLysRS in the reaction of aminoacylation did not demonstrate any effect on this activity. One could suggest that anti-pre-MSK monospecific antibodies were directed against non-catalytic domains of both enzymes investigated (data not shown).
The data of the cross-aminoacylation experi ments (Fig. 4) have shown unusual properties of the mammalian mitochondrial LysRS -a high level of aminoacylation of the cytoplasmic tRNA by the mito chondrial enzyme comparing with that for the mito chondrial tRNAs. We have found that mtLysRS aminoacylated the cytoplasmic tRNAs with the same efficiency as LysRS from cytoplasmic high molecular weight complex (ctLysRS). On the other hand, mtLysRS aminoacylated the mitochondrial tRNAs but did not aminoacylate E. coli tRNAs in fact. In contrast yeast mtLysRS is known to aminoacylate E. coli tRNA with the same efficiency as yeast mito chondrial tRNA but practically is not able to amino acylate the cytoplasmic tRNA from yeast [15] . The data published recently about expression and charac terization of the human mitochondrial PheRS [16] and LeuRS [17] have shown that these enzymes expressed in functionally active monomelic form are able to aminoacylate E. coli tRNA but less effectively than the yeast cytoplasmic aaRSs. Whether the dis tinct properties of mtLysRSs from higher eukaryotes revealed are specific or common features of other mammalian mitochondrial aaRSs -is to be eluci dated.
Most eukaryotic cells possess at least two compartmentally distinct sets of aaRSs, one located in the cytoplasm, and the other -in mitochondria (plants have the third set of chloroplast-specific synthetases). In some instances the same gene can code for both the mitochondrial and cytoplasmic aaRSs [18, 19] . More commonly, however, the functionally equivalent homologues are encoded by different genes. This is the case for the two lysyl-tRNA synthetases (KRS and MSK) of yeast. The gene KRS1, described by Mirande and Waller [20] , has been shown to code for the cytoplasmic LysRS. The MSK1 gene, reported by Gatti and Tsagoloff [15] , codes for the homologous yeast mitochondrial synthetase. However, concerning the LysRSs from higher eukaryotes, our knowledge is restricted to the information on the cytoplasmic synthetases functioning in the high molecular weight complex.
Based on the theory of Wong [21 ] that the genetic code may have evolved «hand-in-hand» with biosynthetic pathways for new amino acids and the hypothesis about mitochondria as prokaryotic endosymbiont incorporated into ancient eukaryotic cells [22] [23] [24] [25] , our data on the immunochemical crossreactivity between the cytoplasmic and mitochondrial mammalian lysyl-tRNA synthetases taken together with those on the cross-aminoacylation (Fig. 4) allow us to suppose that the mitochondrial and cytoplasmic lysyl-tRNA synthetases of mammals could be enco ded by the same gene. Our suggestion has been approved by recently published data concerning the unusual alternative splicing of the human lysyl-tRNA synthetase gene which encodes for both the cyto plasmic and mitochondrial enzymes [26 ] .
Further investigation of the mammalian mito chondrial LysRS is important not only for solving many questions in the protein biosynthesis, molecular import into organelles, molecular evolution of aaRSs, but has a practical value as many severe pathologies are connected with mitochondrial disfunctions, espe cially with mutations in tRNA Lys gene and defects in the protein importing machine, with a leading role of KRS and preMSK. 
